title: Anti-CTLA-4 antibody-induced Guillain-Barré syndrome in a melanoma patient.
authors.affiliation: Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
authors.forename: S
authors.initials: S
authors.lastname: Wilgenhof
authors.affiliation: Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium. Electronic address: Bart.Neyns@uzbrussel.be.
authors.forename: B
authors.initials: B
authors.lastname: Neyns
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D015703:Antigens, CD / Q000276:immunology*; D060908:CTLA-4 Antigen; D005260:Female; D020275:Guillain-Barre Syndrome / Q000139:chemically induced* / Q000276:immunology; D006801:Humans; D000074324:Ipilimumab; D008545:Melanoma / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D000074324:Ipilimumab